SEC Tracker
Get the app
ULS · XBRL financial data

UL Solutions financial statements, every quarter

The same tables from 11 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ULS's year ends in late December)

In millions of dollarsMar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers670730731739*705776783789*758816823
Cost of revenue351364373389*364393389397*377399400
Selling, general and administrative228240228235*232244238239*243267260
Operating income (loss)91126130115*109139156118*138150162
Interest expense15131413*1210109*856
Other income (expense)211(4)*0(2)2(1)*—24
Income tax expense (benefit)1328227*23284034*328443
Net income (loss)561018881*679110067*92246108
Earnings per share, basic USD per share0.280.510.440.41*0.340.450.500.33*0.461.220.53
Earnings per share, diluted USD per share0.280.500.440.40*0.330.450.490.33*0.451.210.53
Weighted average shares, basic millions of shares200200200200*200201201202*201202202
Weighted average shares, diluted millions of shares200201202201*203203203203*204204204

Balance sheet

CSV

Fiscal quarters (ULS's year ends in late December)

In millions of dollarsMar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents3442953272982672722552952584341,016
Accounts receivable429381354380463424386422497471448
Total current assets1,0519579779219981,0099951,0001,0471,2341,778
Property and equipment, net———631———699———
Right-of-use asset147145183186182188184179173166162
Goodwill618628651633641656655656643642648
Total assets2,8192,7422,8772,8002,8782,9222,8982,9212,9553,1193,689
Accounts payable156134138182143139151183168179177
Current portion of long-term debt122537500000———
Total current liabilities829740745740804765749760899866850
Long-term debt867785760692653608544491357301764
Lease liability, non-current116117153155150155150149141136132
Total liabilities2,1361,9561,9811,8691,8941,8091,6781,6271,6191,4991,951
Retained earnings55131194250291356429470533750828
Total stockholders' equity6717698729049701,0931,1931,2621,3191,5951,703
Total liabilities and equity2,8192,7422,8772,8002,8782,9222,8982,9212,9553,1193,689
Common shares outstanding (cover page) millions of shares200200200200———201———

Cash flows

CSV

Fiscal quarters (ULS's year ends in late December)

In millions of dollarsMar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)561018881*679110067*92246108
Stock-based compensation06*10*7*813*15*11*1223*23*
Depreciation and amortization4141*43*47*4546*46*51*4746*49*
Net cash from operating activities141103*150*130*154147*155*144*219160*215*
Purchases of property and equipment5756*66*58*5142*46*58*6969*61*
Net cash from investing activities(57)(36)*(82)*(59)*(50)(57)*(76)*(21)*(61)131*(66)*
Dividends paid2525*25*25*2626*26*26*2929*30*
Proceeds from long-term debt200*88*73*6288*134*508*1870*537*
Repayments of long-term debt4570*103*128*152133*199*561*32157*74*
Net cash from financing activities(49)(110)*(43)*(82)*(135)(86)*(93)*(82)*(194)(114)*436*
Net change in cash29(49)*32*(29)*(31)5*(17)*40*(37)176*582*

Compare with peers

SIC 8734 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8734 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
UL Solutions1,016823215*not reported 10-QSep 30, 2026
Medpace Holdings705716217*28.0M 10-QSep 30, 2026
Charles River Laboratories International200983254*47.9M 10-QSep 26, 2026
Incyte3,2761,557(675)*203.8M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.